IDEXX Laboratories, Inc. Share Price
Equities
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
523.92 USD | +0.78% |
|
-0.57% | +26.72% |
06-20 | IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-28-2025 10:55 AM | |
06-19 | IDEXX Laboratories, Inc., Q1 2025 Earnings Call, May 01, 2025 |
Capitalization | 41.81B 36.29B 34.18B 31.09B 57.41B 3,619B 64.82B 403B 155B 1,657B 157B 154B 6,106B | P/E ratio 2025 * |
42.7x | P/E ratio 2026 * | 38.1x |
---|---|---|---|---|---|
Enterprise value | 42.93B 37.27B 35.1B 31.93B 58.95B 3,716B 66.55B 414B 159B 1,702B 161B 158B 6,270B | EV / Sales 2025 * |
10.4x | EV / Sales 2026 * | 9.53x |
Free-Float |
75.42% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: IDEXX Laboratories, Inc.
More recommendations
More press releases
1 day | +0.78% | ||
1 week | -0.57% | ||
Current month | +2.06% | ||
1 month | +0.43% | ||
3 months | +24.11% | ||
6 months | +28.09% | ||
Current year | +26.72% |
1 week | 513.92 | ![]() | 530.12 |
1 month | 496.61 | ![]() | 530.73 |
Current year | 356.14 | ![]() | 530.73 |
1 year | 356.14 | ![]() | 530.73 |
3 years | 317.06 | ![]() | 583.39 |
5 years | 311.48 | ![]() | 706.95 |
10 years | 61.58 | ![]() | 706.95 |
Manager | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 64 | 27/06/2019 | |
Martin Smith
COO | Chief Operating Officer | 57 | 31/12/2024 |
Michael Lane
CTO | Chief Tech/Sci/R&D Officer | 57 | 14/01/2020 |
Director | Title | Age | Since |
---|---|---|---|
M. Szostak
BRD | Director/Board Member | 74 | 15/07/2012 |
Director/Board Member | 64 | 22/10/2019 | |
Director/Board Member | 63 | 14/07/2013 |
Name | Weight | AuM | 1st Jan change | |
---|---|---|---|---|
1.59% | 21 M€ | +0.15% | - |
Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
---|---|---|---|---|---|---|
+0.78% | -0.57% | +4.03% | +59.71% | 41.81B | ||
Average | +0.78% | -0.81% | +4.03% | +59.71% | 41.81B | |
Weighted average by Cap. | +0.78% | -0.81% | +4.03% | +59.71% |
2025 * | 2026 * | |
---|---|---|
Net sales | 4.14B 3.59B 3.38B 3.08B 5.68B 358B 6.41B 39.93B 15.31B 164B 15.52B 15.19B 604B | 4.46B 3.87B 3.64B 3.31B 6.12B 386B 6.91B 43.01B 16.49B 177B 16.72B 16.36B 651B |
Net income | 985M 855M 805M 732M 1.35B 85.23B 1.53B 9.5B 3.64B 39.04B 3.69B 3.62B 144B | 1.09B 948M 893M 812M 1.5B 94.55B 1.69B 10.54B 4.04B 43.31B 4.1B 4.01B 160B |
Net Debt | 1.12B 972M 916M 833M 1.54B 96.96B 1.74B 10.81B 4.15B 44.41B 4.2B 4.11B 164B | 660M 573M 540M 491M 907M 57.14B 1.02B 6.37B 2.44B 26.17B 2.48B 2.42B 96.41B |
More financial data
* Estimated data
Employees
11,000
Calendar
Date | Price | Change | Volume |
---|---|---|---|
20/06/25 | 523.92 $ | +0.78% | 1,052,193 |
18/06/25 | 519.85 $ | -0.14% | 590,939 |
17/06/25 | 520.59 $ | -1.55% | 430,708 |
16/06/25 | 528.77 $ | +1.16% | 371,840 |
13/06/25 | 522.70 $ | -0.80% | 411,465 |
Delayed Quote Nasdaq, June 20, 2025 at 09:00 pm
More quotesSell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
519.85USD
Average target price
507.08USD
Spread / Average Target
-2.46%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- IDXX Stock
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition